These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9093614)

  • 1. Meningitis outbreaks and vaccination strategy.
    Varaine F; Caugant DA; Riou JY; Kondé MK; Soga G; Nshimirimana D; Muhirwa G; Ott D; Høiby EA; Fermon F; Moren A
    Trans R Soc Trop Med Hyg; 1997; 91(1):3-7. PubMed ID: 9093614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiological and epidemiological investigation of the Neisseria meningitidis serogroup A epidemic in Niger in 2009: last wave before the introduction of the serogroup A meningococcal conjugate vaccine?
    Collard JM; Maman Z; Abani A; Mainasara HB; Djibo S; Yacouba H; Maitournam R; Sidikou F; Nicolas P; Rocourt J; Jusot JF
    Epidemiol Infect; 2011 Nov; 139(11):1656-60. PubMed ID: 21251346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt.
    Kuznik A; Iliyasu G; Lamorde M; Mahmud M; Musa BM; Nashabaru I; Obaro S; Mohammed I; Habib AG
    PLoS One; 2017; 12(11):e0188595. PubMed ID: 29190699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive immunisation could reduce the risk of meningococcal epidemics in the African meningitis belt.
    Chippaux JP; Campagne G; Djibo S; Cissé L; Hassane A; Kanta I
    Ann Trop Med Parasitol; 1999 Jul; 93(5):505-10. PubMed ID: 10690246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.
    Mohammed I; Obineche EN; Onyemelukwe GC; Zaruba K
    J Infect; 1984 Sep; 9(2):190-6. PubMed ID: 6438244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic Response.
    Cooper LV; Ronveaux O; Fernandez K; Lingani C; Goumbi K; Ihekweazu C; Preziosi MP; Durupt A; Trotter CL
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S244-S252. PubMed ID: 31671446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
    Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
    Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new epidemic of meningococcal meningitis in Burundi].
    Ndihokubwayo JB; Nyongabo T; Nkurikiye S; Adegbinni R
    Med Trop (Mars); 1997; 57(1):98-9. PubMed ID: 9289623
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of a meningococcal meningitis outbreak in Niger - potential effectiveness of reactive prophylaxis.
    Hitchings MDT; Coldiron ME; Grais RF; Lipsitch M
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007077. PubMed ID: 30856166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Control of an epidemic of meningococcal meningitis in Central Africa].
    Merlin M; Martet G; Debonne JM; Nicolas P; Bailly C; Yazipo D; Bougère J; Todesco A; Laroche R
    Sante; 1996; 6(2):87-95. PubMed ID: 8705135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis.
    Pérez-Trallero E; Vicente D; Montes M; Cisterna R
    Lancet; 2002 Sep; 360(9337):953. PubMed ID: 12354504
    [No Abstract]   [Full Text] [Related]  

  • 13. Time delays in the response to the Neisseria meningitidis serogroup C outbreak in Nigeria - 2017.
    Hassan A; Mustapha GU; Lawal BB; Na'uzo AM; Ismail R; Womi-Eteng Oboma E; Oyebanji O; Agenyi J; Thomas C; Balogun MS; Dalhat MM; Nguku P; Ihekweazu C
    PLoS One; 2018; 13(6):e0199257. PubMed ID: 29920549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].
    du Châtelet IP; Alonso JM; Taha MK
    Bull Soc Pathol Exot; 2002 Dec; 95(5):323-4; discussion 324-5. PubMed ID: 12696368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94.
    Guibourdenche M; Høiby EA; Riou JY; Varaine F; Joguet C; Caugant DA
    Epidemiol Infect; 1996 Apr; 116(2):115-20. PubMed ID: 8620901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
    da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
    Sante; 2003; 13(4):215-23. PubMed ID: 15047438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis.
    Parent du Châtelet I; Gessner BD; da Silva A
    Vaccine; 2001 May; 19(25-26):3420-31. PubMed ID: 11348706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemic meningitis in 2013 in Republic of Guinea: Nesseria meningitidis W135 emergence].
    Traoré FA; Sako FB; Sylla D; Kader DS; Bangoura M; Traoré M; Keita A; Sidibé A; Keita S; Barry M; Cisse M; Touré A
    Bull Soc Pathol Exot; 2016 Dec; 109(5):364-367. PubMed ID: 27578236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135.
    Boisier P; Djibo S; Sidikou F; Mindadou H; Kairo KK; Djibo A; Goumbi K; Chanteau S
    Trop Med Int Health; 2005 May; 10(5):435-43. PubMed ID: 15860090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger.
    Boisier P; Nicolas P; Djibo S; Taha MK; Jeanne I; Maïnassara HB; Tenebray B; Kairo KK; Giorgini D; Chanteau S
    Clin Infect Dis; 2007 Mar; 44(5):657-63. PubMed ID: 17278055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.